NZ741606A - Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency - Google Patents
Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiencyInfo
- Publication number
- NZ741606A NZ741606A NZ74160613A NZ74160613A NZ741606A NZ 741606 A NZ741606 A NZ 741606A NZ 74160613 A NZ74160613 A NZ 74160613A NZ 74160613 A NZ74160613 A NZ 74160613A NZ 741606 A NZ741606 A NZ 741606A
- Authority
- NZ
- New Zealand
- Prior art keywords
- cis
- retinyl
- subject
- therapeutic dose
- synthetic retinal
- Prior art date
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261605729P | 2012-03-01 | 2012-03-01 | |
US201261642212P | 2012-05-03 | 2012-05-03 | |
US201261644360P | 2012-05-08 | 2012-05-08 | |
NZ72491013 | 2013-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ741606A true NZ741606A (en) | 2019-10-25 |
Family
ID=68318671
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ74160613A NZ741606A (en) | 2012-03-01 | 2013-03-01 | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency |
Country Status (1)
Country | Link |
---|---|
NZ (1) | NZ741606A (en) |
-
2013
- 2013-03-01 NZ NZ74160613A patent/NZ741606A/en not_active IP Right Cessation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ629267A (en) | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency | |
PH12021550328A1 (en) | Methods of reducing the need for peripheral arterial revascularization in a statin-treated subject | |
ZA202110659B (en) | Methods of reducing the risk of cardiovascular events in a subject | |
EP4299093A3 (en) | Wearable automatic injection device for controlled administration of therapeutic agents | |
EP3682875A3 (en) | Methods of treating pediatric metabolic syndrome | |
MX2011008448A (en) | Use of eicosapentaenoic acid ethyl ester for treating hypertriglyceridemia. | |
EP4342546A3 (en) | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy | |
MY173215A (en) | Acetylcysteine compositions and methods of use thereof | |
MX2013002725A (en) | Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle. | |
MX350666B (en) | Methods and compositions for treating hyperuricemia and metabolic disorders associated with hyperuricemia. | |
RU2016106829A (en) | The use of acetyl CoA carboxylase inhibitors for the treatment of acne vulgaris | |
SG10201906172XA (en) | Regulation of glucose metabolism using anti-cgrp antibodies | |
MX2015015036A (en) | Methods for improving lipid profiles using atrasentan. | |
WO2013155528A3 (en) | Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels | |
MX348418B (en) | Ocular composition containing bromfenac with increased bioavailability. | |
GB2533235A (en) | Vesicles | |
NZ603331A (en) | Therapeutic regimens and methods for treating or ameliorating visual disorders associated with an endogenous retinoid deficiency | |
MX359672B (en) | Methods for chronic pain management and treatment using hcg. | |
BR112015003733A2 (en) | extended release compositions of an aminoalkyl nitrate | |
NZ741606A (en) | Therapeutic regimens and methods for improving visual function in visual disorders associated with an endogenous retinoid deficiency | |
NZ604009A (en) | A combination composition comprising ibuprofen and paracetamol | |
MX359686B (en) | Metadichol r liquid and gel nanoparticle formulations. | |
SG11201808241WA (en) | Composition for skin moisturization or skin whitening, containing pentacyclic triterpene caffeic acid esters | |
PH12021500016A1 (en) | Methods of reducing the risk of cardiovascular events in a subject | |
MX2022015602A (en) | Methods of treating visual disorders using daily low dosing of a retinoid compound. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ASS | Change of ownership |
Owner name: RETINAGENIX, LLC, US Effective date: 20190329 |
|
PSEA | Patent sealed | ||
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 01 MAR 2020 BY SHELSTON IP PTY LTD Effective date: 20200128 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 MAR 2021 BY CPA GLOBAL Effective date: 20200227 |
|
ASS | Change of ownership |
Owner name: RETINAGENIX THERAPEUTICS, INC., US Effective date: 20210120 |
|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 01 MAR 2022 BY CPA GLOBAL Effective date: 20210305 |
|
ASS | Change of ownership |
Owner name: RETINAGENIX HOLDING, US Effective date: 20211020 |
|
LAPS | Patent lapsed |